Abstract
Current Neuropharmacology
Title: The Concept of “Neuroprotection” in Neurological Diseases
Volume: 2 Issue: 3
Author(s): Paolo Calabresi, Cinzia Costa, Diego Centonze, Antonio Pisani and Giorgio Bernardi
Affiliation:
Abstract:
Export Options
About this article
Cite this article as:
Calabresi Paolo, Costa Cinzia, Centonze Diego, Pisani Antonio and Bernardi Giorgio, The Concept of “Neuroprotection” in Neurological Diseases, Current Neuropharmacology 2004; 2 (3) . https://dx.doi.org/10.2174/1570159043359701
DOI https://dx.doi.org/10.2174/1570159043359701 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Editorial (Thematic Issue: Novel Perspectives for Parkinson’s Disease Therapy: Insights from the Latest Advances in Disease Pathophysiology, Diagnostic and Experimental Tools and Molecular Targets)
CNS & Neurological Disorders - Drug Targets Genetic Anomalies of the Respiratory Tract
Current Respiratory Medicine Reviews Bronchiolar Disorders In Childhood
Current Pediatric Reviews Off-Label Trazodone Prescription: Evidence, Benefits and Risks
Current Pharmaceutical Design Connecting Parkinsons Disease and Drug Addiction: Common Players Reveal Unexpected Disease Connections and Novel Therapeutic Approaches
Current Pharmaceutical Design Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) GPCR Heteromers and their Allosteric Receptor-Receptor Interactions
Current Medicinal Chemistry Effects of Eugenol on the Central Nervous System: Its Possible Application to Treatment of Alzheimers Disease, Depression, and Parkinsons Disease
Current Bioactive Compounds Rehabilitation of Schizophrenic Patients
Current Pharmaceutical Design Neuropsychological Aspects of Dual Diagnosis
Current Drug Abuse Reviews Pharmacogenetics and Drug Therapy in Psychiatry - The Role of the CYP2D6 Polymorphism
Current Pharmaceutical Design Will it Ever Become Possible to Prevent Dopaminergic Neuronal Degeneration?
CNS & Neurological Disorders - Drug Targets Phosphodiesterases as Therapeutic Targets for Huntington’s Disease
Current Pharmaceutical Design Pharmacogenetic and Pharmacogenomic Research in Psychiatry: Current Advances and Clinical Applications
Current Pharmacogenomics Development and Applications of Non-HIV-Based Lentiviral Vectors in Neurological Disorders
Current Gene Therapy Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders
Current Neuropharmacology Applications of Lentiviral Vectors for Biology and Gene Therapy of Neurological Disorders
Current Gene Therapy Functional MRI of the Pancreaticobiliary System
Current Medical Imaging Do mtDNA Mutations Participate in the Pathogenesis of Sporadic Parkinsons Disease?
Current Genomics Neurobiology of Sleep Disturbances in Neurodegenerative Disorders
Current Pharmaceutical Design